Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-10-18 Sale |
2024-10-22 4:17 pm |
Enliven Therapeutics Inc. | ELVN | Collins Helen Louise CHIEF MEDICAL OFFICER |
816 | $30 | $24,482 | 266,268 (Direct) |
View |
| 2024-04-11 Sale |
2024-04-15 7:02 pm |
Enliven Therapeutics Inc. | ELVN | Collins Helen Louise CHIEF MEDICAL OFFICER |
20,000 | $25.07 | $501,478 | 267,084 (Direct) |
View |
| 2021-04-16 Sale |
2021-04-19 7:53 pm |
FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer |
135,547 | $38 | $5,150,786 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-06 Option Award |
2025-02-10 5:25 pm |
N/A 2035-02-06 |
Enliven Therapeutics Inc. | ELVN | Collins Helen Louise CHIEF MEDICAL OFFICER |
171,000 | $0 | 171,000 (Direct) |
View |
| 2024-10-18 Exercise |
2024-10-22 4:17 pm |
N/A 2031-06-17 |
Enliven Therapeutics Inc. | ELVN | Collins Helen Louise CHIEF MEDICAL OFFICER |
816 | $0 | 266,268 (Direct) |
View |
| 2024-10-18 Exercise |
2024-10-22 4:17 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Collins Helen Louise CHIEF MEDICAL OFFICER |
816 | $2.48 | 266,268 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A 2034-06-04 |
Kura Oncology Inc. | KURA | Collins Helen Louise Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-07 4:12 pm |
N/A 2034-06-06 |
IO Biotech Inc. | IOBT | Collins Helen Louise Director |
45,642 | $0 | 45,642 (Direct) |
View |
| 2024-04-11 Exercise |
2024-04-15 7:02 pm |
N/A 2031-06-17 |
Enliven Therapeutics Inc. | ELVN | Collins Helen Louise CHIEF MEDICAL OFFICER |
20,000 | $0 | 267,084 (Direct) |
View |
| 2024-04-11 Exercise |
2024-04-15 7:02 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Collins Helen Louise CHIEF MEDICAL OFFICER |
20,000 | $2.48 | 267,084 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 8:46 pm |
N/A 2034-02-12 |
Enliven Therapeutics Inc. | ELVN | Collins Helen Louise CHIEF MEDICAL OFFICER |
185,000 | $0 | 185,000 (Direct) |
View |
| 2023-11-15 Option Award |
2023-11-17 4:47 pm |
N/A 2033-11-15 |
IO Biotech Inc. | IOBT | Collins Helen Louise Director |
64,238 | $0 | 64,238 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 4:45 pm |
N/A 2033-05-30 |
Kura Oncology Inc. | KURA | Collins Helen Louise Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2023-04-04 Option Award |
2023-04-06 8:32 pm |
N/A 2033-04-04 |
Enliven Therapeutics Inc. | ELVN | Collins Helen Louise Chief Medical Officer |
206,000 | $0 | 206,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 9:32 pm |
N/A 2031-06-17 |
Enliven Therapeutics Inc. | ELVN | Collins Helen Louise Chief Medical Officer |
287,084 | $0 | 287,084 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-23 4:54 pm |
N/A 2032-06-20 |
Kura Oncology Inc. | KURA | Collins Helen Louise Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2021-07-28 Option Award |
2021-07-29 5:17 pm |
N/A 2031-07-27 |
Kura Oncology Inc. | KURA | Collins Helen Louise Director |
65,166 | $0 | 65,166 (Direct) |
View |
| 2021-03-31 Gift |
2021-04-19 7:53 pm |
N/A N/A |
FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer |
8,085 | $0 | 0 (Direct) |
View |
| 2021-04-16 Option Award |
2021-04-19 7:53 pm |
N/A N/A |
FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer |
66,000 | $0 | 0 (Direct) |
View |
| 2021-02-26 Tax Withholding |
2021-03-02 12:08 pm |
N/A N/A |
FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer |
1,158 | $22.23 | 77,632 (Direct) |
View |
| 2021-02-24 Tax Withholding |
2021-02-26 2:36 pm |
N/A N/A |
FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer |
5,091 | $25.71 | 78,790 (Direct) |
View |
| 2021-02-25 Tax Withholding |
2021-02-26 2:36 pm |
N/A N/A |
FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer |
1,653 | $23.08 | 78,790 (Direct) |
View |
| 2020-12-11 Tax Withholding |
2020-12-15 12:00 pm |
N/A N/A |
FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer |
11,583 | $16.14 | 85,534 (Direct) |
View |
| 2020-12-11 Exercise |
2020-12-15 12:00 pm |
N/A N/A |
FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer |
22,000 | $0 | 85,534 (Direct) |
View |
| 2020-11-11 Exercise |
2020-11-13 12:25 pm |
N/A N/A |
FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer |
22,000 | $0 | 97,117 (Direct) |
View |
| 2020-11-11 Tax Withholding |
2020-11-13 12:25 pm |
N/A N/A |
FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer |
11,039 | $18 | 97,117 (Direct) |
View |
| 2020-08-20 Tax Withholding |
2020-08-24 1:46 pm |
N/A N/A |
FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer |
827 | $4.69 | 64,156 (Direct) |
View |